Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 262

1.

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.

Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, de Zeeuw D, Ouwendijk RJ.

Ann Intern Med. 2003 Jul 15;139(2):90-6.

PMID:
12859158
[PubMed - indexed for MEDLINE]
2.

The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial.

Zandbergen AA, Lamberts SW, Baggen MG, Janssen JA, Boersma E, Bootsma AH.

Clin Endocrinol (Oxf). 2006 Feb;64(2):203-8.

PMID:
16430721
[PubMed - indexed for MEDLINE]
3.

Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.

Agha A, Bashir K, Anwar E.

Nepal Med Coll J. 2007 Jun;9(2):79-83.

PMID:
17899953
[PubMed - indexed for MEDLINE]
4.

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.

Tan KC, Chow WS, Ai VH, Lam KS.

Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6.

PMID:
11921421
[PubMed - indexed for MEDLINE]
5.

Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.

Agha A, Amer W, Anwar E, Bashir K.

Saudi J Kidney Dis Transpl. 2009 May;20(3):429-35.

PMID:
19414946
[PubMed - indexed for MEDLINE]
Free Article
6.

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M.

Ann Intern Med. 1993 Apr 15;118(8):577-81.

PMID:
8452322
[PubMed - indexed for MEDLINE]
7.

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.

Ann Intern Med. 1998 Jun 15;128(12 Pt 1):982-8.

PMID:
9625684
[PubMed - indexed for MEDLINE]
8.

Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion.

Satoh S, Horikawa Y, Kakinuma H, Tsuchiya N, Wang L, Kato T, Habuchi T.

Int J Urol. 2004 Aug;11(8):585-91.

PMID:
15285746
[PubMed - indexed for MEDLINE]
9.

Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE.

Diabetes Care. 2002 Jun;25(6):1072-7.

PMID:
12032117
[PubMed - indexed for MEDLINE]
10.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

PMID:
16095545
[PubMed - indexed for MEDLINE]
Free Article
11.

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

Kidney Int. 2000 Feb;57(2):590-600.

PMID:
10652036
[PubMed - indexed for MEDLINE]
Free Article
12.

Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

Lewis EJ, Lewis JB.

Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.

PMID:
14586737
[PubMed - indexed for MEDLINE]
13.

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Viberti G, Wheeldon NM; MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators.

Circulation. 2002 Aug 6;106(6):672-8.

PMID:
12163426
[PubMed - indexed for MEDLINE]
Free Article
14.

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM.

Kidney Int. 2004 Jun;65(6):2309-20.

PMID:
15149345
[PubMed - indexed for MEDLINE]
16.

Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.

Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM.

Nephrol Dial Transplant. 2003 Sep;18(9):1806-13.

PMID:
12937228
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study.

Tütüncü NB, Gürlek A, Gedik O.

Acta Diabetol. 2001 Dec;38(4):157-61.

PMID:
11855793
[PubMed - indexed for MEDLINE]
19.

Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study.

Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE.

J Intern Med. 2003 Aug;254(2):147-58.

PMID:
12859696
[PubMed - indexed for MEDLINE]
20.

Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.

Chan JC, Critchley JA, Tomlinson B, Chan TY, Cockram CS.

Am J Nephrol. 1997;17(1):72-80.

PMID:
9057957
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk